サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1387493

血糖モニタリングシステム市場レポート：2030年までの動向、予測、競合分析

Blood Glucose Monitoring System Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

血糖モニタリングシステム市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

血糖モニタリングシステムの動向と予測

世界の血糖モニタリングシステム市場は、2024年から2030年までのCAGRが7.5%で、2030年までに推定345億米ドルに達すると予想されます。この市場の主な促進要因は、糖尿病有病率の増加、高齢化による糖尿病感受性の増加、新製品のリリースや糖尿病予防に対する意識の高まりです。世界の血糖モニタリングシステム市場の将来は、指先と代替部位市場の機会によって有望視されています。

血糖モニタリングシステム市場の洞察

Lucintelは、糖尿病患者の増加とグルコースレベルの定期的なモニタリングに関する意識の高まりにより、予測期間中、在宅ケアが最大のセグメントであり続けると予測しています。

北米は、肥満率の上昇、高額医療、新製品イントロダクション、技術向上により、予測期間中も最大地域であり続ける。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の血糖モニタリングシステム市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の血糖モニタリングシステム市場動向（2018-2023）と予測（2024-2030）
  • 検査部位別の世界の血糖モニタリングシステム市場
    • 指先
    • 代替部位
  • 製品別の世界の血糖モニタリングシステム市場
    • セルフモニタリング
    • CGMS
  • 患者ケア別の世界の血糖モニタリングシステム市場
    • 病院
    • 在宅ケア
  • 用途別の世界の血糖モニタリングシステム市場
    • 1型
    • 2型
    • 妊娠糖尿病
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の血糖モニタリングシステム市場
  • 北米の血糖モニタリングシステム市場
  • 欧州の血糖モニタリングシステム市場
  • アジア太平洋の血糖モニタリングシステム市場
  • その他地域の血糖モニタリングシステム市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 検査部位別の世界の血糖モニタリングシステム市場の成長機会
    • 製品別の世界の血糖モニタリングシステム市場の成長機会
    • 患者ケア別の世界の血糖モニタリングシステム市場の成長機会
    • 用途別の世界の血糖モニタリングシステム市場の成長機会
    • 地域別の世界の血糖モニタリングシステム市場の成長機会
  • 世界の血糖モニタリングシステム市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の血糖モニタリングシステム市場の能力拡大
    • 世界の血糖モニタリングシステム市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
目次

Blood Glucose Monitoring System Trends and Forecast

The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets. The global blood glucose monitoring system market is expected to reach an estimated $34.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalence of diabetes, aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

A more than 150-page report is developed to help in your business decisions.

Blood Glucose Monitoring System by Segment

The study includes a forecast for the global blood glucose monitoring system by testing site, product, patient care setting, application, and region.

Blood Glucose Monitoring System Market by Testing Site [Shipment Analysis by Value from 2018 to 2030]:

  • Fingertip
  • Alternate Site

Blood Glucose Monitoring System Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Self-Monitoring
  • Continuous Glucose Monitoring Devices

Blood Glucose Monitoring System Market by Patient Care Setting [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Homecare

Blood Glucose Monitoring System Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Type 1
  • Type 2
  • Gestational Diabetes
  • Others

Blood Glucose Monitoring System Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Blood Glucose Monitoring System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies blood glucose monitoring system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blood glucose monitoring system companies profiled in this report include-

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Blood Glucose Monitoring System Market Insights

Lucintel forecasts that homecare will remain the largest segment over the forecast period due to rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.

North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Features of the Global Blood Glucose Monitoring System Market

Market Size Estimates: Blood glucose monitoring system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Blood glucose monitoring system market size by various segments, such as by testing site, product, patient care setting, application, and region in terms of value ($B).

Regional Analysis: Blood glucose monitoring system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different testing site, product, patient care setting, application, and regions for the blood glucose monitoring system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the blood glucose monitoring system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the blood glucose monitoring system market size?

Answer: The global blood glucose monitoring system market is expected to reach an estimated $34.5 billion by 2030.

Q2. What is the growth forecast for blood glucose monitoring system market?

Answer: The global blood glucose monitoring system market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the blood glucose monitoring system market?

Answer: The major drivers for this market are growing prevalence of diabetes, aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

Q4. What are the major segments for blood glucose monitoring system market?

Answer: The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets.

Q5. Who are the key blood glucose monitoring system market companies?

Answer: Some of the key blood glucose monitoring system companies are as follows:

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6. Which blood glucose monitoring system market segment will be the largest in future?

Answer: Lucintel forecasts that homecare will remain the largest segment over the forecast period due to rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.

Q7. In blood glucose monitoring system market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the blood glucose monitoring system market by testing site (fingertip and alternate site), product (self-monitoring and continuous glucose monitoring devices), patient care setting (hospital and homecare), application (type 1, type 2, gestational diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Blood Glucose Monitoring System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Blood Glucose Monitoring System Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Blood Glucose Monitoring System Market by Testing Site
    • 3.3.1: Fingertip
    • 3.3.2: Alternate Site
  • 3.4: Global Blood Glucose Monitoring System Market by Product
    • 3.4.1: Self-Monitoring
    • 3.4.2: Continuous Glucose Monitoring Devices
  • 3.5: Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 3.5.1: Hospital
    • 3.5.2: Homecare
  • 3.6: Global Blood Glucose Monitoring System Market by Application
    • 3.6.1: Type 1
    • 3.6.2: Type 2
    • 3.6.3: Gestational Diabetes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Blood Glucose Monitoring System Market by Region
  • 4.2: North American Blood Glucose Monitoring System Market
    • 4.2.2: North American Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.3: European Blood Glucose Monitoring System Market
    • 4.3.1: European Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.3.2: European Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.4: APAC Blood Glucose Monitoring System Market
    • 4.4.1: APAC Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.4.2: APAC Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.5: ROW Blood Glucose Monitoring System Market
    • 4.5.1: ROW Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.5.2: ROW Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Testing Site
    • 6.1.2: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Product
    • 6.1.3: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 6.1.4: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Application
    • 6.1.5: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Region
  • 6.2: Emerging Trends in the Global Blood Glucose Monitoring System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Blood Glucose Monitoring System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Glucose Monitoring System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott